Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Biosimilars Set to Take a Big Market Share in the US
-
- Four Top Lupus Stories from ACR Annual Meeting
- FDA Approves Exemption for Implantable Bioelectric Therapy for RA
- FDA Proposes New Plan to Protect Against Potentially Harmful Homeopathic Drugs
- Beyond Temporary Relief: New OA Treatments Target Pain Mechanisms
- Biosimilars Savings: “...the Substance of Things Hoped For” Jonathan Kay, MD
- ACR, EULAR Release Classification Criteria for Idiopathic Inflammatory Myopathies
- Maternal RA Linked to Thyroid Disease, Epilepsy in Children
- Tailored, Systematic Rituximab Regimens Have Similar Relapse Rates in ANCA-associated Vasculitis
-
- New Studies, Technology and Criteria Improve Understanding of Vasculitis
- House, Senate Pass Tax Reform; Experts Say it is ‘Not Good News’ for Health Care
- Net Neutrality Repeal May Diminish Telemedicine Access, Harm Small Practices